A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects

NCT00316524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

745

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: MVA-BN® (IMVAMUNE)
BIOLOGICAL: Placebo

Sponsor

Bavarian Nordic

Collaborators

[object Object]